tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

Alterity Therapeutics Issues Over 1.1 Billion Shares
Company AnnouncementsAlterity Therapeutics Issues Over 1.1 Billion Shares
7d ago
Alterity Therapeutics to List New Securities on ASX
PremiumCompany Announcements
Alterity Therapeutics to List New Securities on ASX
7d ago
Alterity Therapeutics raises A$40M in placement
PremiumThe Fly
Alterity Therapeutics raises A$40M in placement
13d ago
ATHE
Alterity Therapeutics Announces Major Securities Issue to Boost Capital
PremiumCompany Announcements
Alterity Therapeutics Announces Major Securities Issue to Boost Capital
14d ago
Alterity Therapeutics Secures A$40 Million to Propel ATH434 Development
PremiumCompany Announcements
Alterity Therapeutics Secures A$40 Million to Propel ATH434 Development
14d ago
JPMorgan Ceases Substantial Holding in Alterity Therapeutics
PremiumCompany AnnouncementsJPMorgan Ceases Substantial Holding in Alterity Therapeutics
17d ago
Alterity Therapeutics Initiates Trading Halt for Capital Raising Announcement
Premium
Company Announcements
Alterity Therapeutics Initiates Trading Halt for Capital Raising Announcement
18d ago
Alterity Therapeutics Ltd (ADR) trading halted, news pending
Premium
The Fly
Alterity Therapeutics Ltd (ADR) trading halted, news pending
18d ago
ATHE
JPMorgan Becomes Substantial Holder in Alterity Therapeutics
PremiumCompany Announcements
JPMorgan Becomes Substantial Holder in Alterity Therapeutics
18d ago
Alterity Therapeutics Discloses Equity Derivative Positions of Point72
PremiumCompany Announcements
Alterity Therapeutics Discloses Equity Derivative Positions of Point72
18d ago
BNYMC Increases Stake in Alterity Therapeutics
PremiumCompany Announcements
BNYMC Increases Stake in Alterity Therapeutics
19d ago
Alterity Therapeutics Completes Significant Share Issuance
PremiumCompany Announcements
Alterity Therapeutics Completes Significant Share Issuance
20d ago
Alterity Therapeutics Quotes Over 164 Million Securities on ASX
PremiumCompany AnnouncementsAlterity Therapeutics Quotes Over 164 Million Securities on ASX
20d ago
Alterity Therapeutics downgraded to Hold from Speculative Buy at Benchmark
Premium
The Fly
Alterity Therapeutics downgraded to Hold from Speculative Buy at Benchmark
20d ago
ATHE
Alterity Therapeutics Announces Major Securities Placement
Premium
Company Announcements
Alterity Therapeutics Announces Major Securities Placement
21d ago
Alterity Therapeutics Secures Funding to Advance Neurodegenerative Drug Development
PremiumCompany Announcements
Alterity Therapeutics Secures Funding to Advance Neurodegenerative Drug Development
21d ago
Alterity Therapeutics price target raised to $12 from $8 at Maxim
PremiumThe Fly
Alterity Therapeutics price target raised to $12 from $8 at Maxim
24d ago
ATHE
Alterity Therapeutics announces ATH434 Phase 2 trial results
PremiumThe Fly
Alterity Therapeutics announces ATH434 Phase 2 trial results
24d ago
ATHE
Alterity Therapeutics Reports Promising Phase 2 Results for MSA Drug ATH434
PremiumCompany Announcements
Alterity Therapeutics Reports Promising Phase 2 Results for MSA Drug ATH434
25d ago
Alterity Therapeutics Initiates Trading Halt Pending Phase II Trial Results
PremiumCompany AnnouncementsAlterity Therapeutics Initiates Trading Halt Pending Phase II Trial Results
27d ago
Alterity Therapeutics Ltd (ADR) trading halted, news pending
Premium
The Fly
Alterity Therapeutics Ltd (ADR) trading halted, news pending
27d ago
ATHE
Alterity Therapeutics reports cash balance of A$4.54M as of December 31
Premium
The Fly
Alterity Therapeutics reports cash balance of A$4.54M as of December 31
1M ago
ATHE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >